IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Merck & Co., Inc.

Q1 2025 Holdings

Filed 2025-05-14 | 12 holdings | $164.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$65.4M2,308,19039.8%
Personalis Inc(PSNL)COM71535D106$49.3M14,044,94330.0%
Kymera Therapeutics Inc(KYMR)COM501575104$21.1M772,16512.9%
Entrada Therapeutics IncCOM29384C908$15.7M1,739,7689.6%
Alector Inc(ALEC)COM014442107$4.4M3,545,7192.7%
Evaxion Biotech A/SSPONSORED ADS29970R204$2.2M1,214,1261.4%
Sutro Biopharma IncCOM869367102$1.8M2,723,5091.1%
Lava Therapeutics NVSHSN51517105$1.5M1,149,3450.9%
Viridian Therapeutics Inc(VRDN)COM92790C104$1.3M93,4140.8%
Xilio Therapeutics Inc(XLO)COM98422T100$1.1M1,483,7580.7%
Carisma Therapeutics Inc(CARM)COM14216R101$456.7K1,473,2400.3%
Neuphoria Therapeutics Inc(NEUP)COM64136E102$57.8K10,0270.0%